1,112 results on '"Zauber, Ann"'
Search Results
2. CLINICOPATHOLOGICAL CHARACTERISTICS AND RISK FACTORS OF YOUNG-ONSET GASTRIC CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
3. Prevalence of Gastric Precursor Lesions in Countries With Differential Gastric Cancer Burden: A Systematic Review and Meta-analysis
4. Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With a Blood Test That Meets the Centers for Medicare & Medicaid Services Coverage Decision
5. Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations
6. Young-onset colorectal cancer
7. Critical Appraisal of Decision Models Used for the Economic Evaluation of Bladder Cancer Screening and Diagnosis: A Systematic Review
8. Early-onset Colorectal Cancer Patients Do Not Require Shorter Intervals for Post-surgical Surveillance Colonoscopy
9. Risk-Stratified Screening for Colorectal Cancer Using Genetic and Environmental Risk Factors: A Cost-Effectiveness Analysis Based on Real-World Data
10. NordICC Trial Results in Line With Expected Colorectal Cancer Mortality Reduction After Colonoscopy: A Modeling Study
11. Factors associated with detection of hereditary diffuse gastric cancer on endoscopy in individuals with germline CDH1 mutations
12. Randomized Trial of Facilitated Adherence to Screening Colonoscopy vs Sequential Fecal-Based Blood Test
13. Bias due to coarsening of time intervals in the inference for the effectiveness of colorectal cancer screening.
14. Projected Colorectal Cancer Incidence and Mortality Based on Observed Adherence to Colonoscopy and Sequential Stool-Based Screening.
15. Cost Effectiveness of Age-Specific Screening Intervals for People With Family Histories of Colorectal Cancer
16. ANALYSES OF PREVENTIVE CARE MEASURES WITH INCOMPLETE HISTORICAL DATA IN ELECTRONIC MEDICAL RECORDS : AN EXAMPLE FROM COLORECTAL CANCER SCREENING
17. Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening.
18. Cystic Fibrosis Colorectal Cancer Screening Consensus Recommendations
19. Systematic meta-analyses and field synopsis of genetic association studies in colorectal adenomas
20. Estimated US Cancer Deaths Prevented With Increased Use of Lung, Colorectal, Breast, and Cervical Cancer Screening
21. Decreased colorectal cancer incidence and mortality in a diverse urban population with increased colonoscopy screening
22. The impact of stratifying by family history in colorectal cancer screening programs.
23. Family history and the natural history of colorectal cancer: systematic review
24. A Summary of the Fight Colorectal Cancer Working Meeting: Exploring Risk Factors and Etiology of Sporadic Early-Age Onset Colorectal Cancer
25. Index colonoscopy-related risk factors for postcolonoscopy colorectal cancers
26. Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death
27. Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population
28. NordICC Trial Results in Line With Expected Colorectal Cancer Mortality Reduction After Colonoscopy: A Modeling Study
29. Germline Variants and Advanced Colorectal Adenomas: Adenoma Prevention with Celecoxib Trial Genome-wide Association Study
30. Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer
31. Transforming Epidemiology for 21st Century Medicine and Public Health
32. Projected long-term effects of colorectal cancer screening disruptions following the COVID-19 pandemic
33. Author response: Projected long-term effects of colorectal cancer screening disruptions following the COVID-19 pandemic
34. Perspective on this Article from Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
35. Data from Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial
36. Perspective from Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial
37. Perspective on This Article from C-reactive Protein and Risk of Colorectal Adenoma According to Celecoxib Treatment
38. Data from The Influence of UGT1A6 Variants and Aspirin Use in a Randomized Trial of Celecoxib for Prevention of Colorectal Adenoma
39. Supplementary Information from Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
40. Data from Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
41. Data from C-reactive Protein and Risk of Colorectal Adenoma According to Celecoxib Treatment
42. Supplementary Table 1 from The Influence of UGT1A6 Variants and Aspirin Use in a Randomized Trial of Celecoxib for Prevention of Colorectal Adenoma
43. Statin Use and the Risk of Breast and Prostate Cancer
44. Endoscopist fatigue estimates and colonoscopic adenoma detection in a large community-based setting
45. Cost-Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer
46. Personalized Multilevel Intervention for Improving Appropriate Use of Colorectal Cancer Screening in Older Adults: A Cluster Randomized Clinical Trial.
47. Risk of Ovarian Cancer According to Use of Antidepressants, Phenothiazines, and Benzodiazepines (United States)
48. NSAIDs and Risk of Colorectal Cancer According to Presence or Absence of Family History of the Disease
49. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test
50. Comparative Effectiveness and Cost-Effectiveness of Current CRC Screening Modalities
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.